VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Wednesday, December 31, 2025

Stock Comparison

Hermes International Societe en commandite par actions vs West Pharmaceutical Services, Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Hermes International Societe en commandite par actions

RMS · Euronext Paris

Market cap (USD)$261.7B
SectorConsumer
CountryFR
Data as of2025-12-30
Moat score
79/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Hermes International Societe en commandite par actions's moat claims, evidence, and risks.

View RMS analysis

West Pharmaceutical Services, Inc.

WST · New York Stock Exchange

Market cap (USD)
SectorHealthcare
CountryUS
Data as of2025-12-22
Moat score
85/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into West Pharmaceutical Services, Inc.'s moat claims, evidence, and risks.

View WST analysis

Comparison highlights

  • Moat score gap: West Pharmaceutical Services, Inc. leads (85 / 100 vs 79 / 100 for Hermes International Societe en commandite par actions).
  • Segment focus: Hermes International Societe en commandite par actions has 7 segments (42.6% in Leather Goods and Saddlery); West Pharmaceutical Services, Inc. has 2 segments (80.7% in Proprietary Products).
  • Primary market structure: Oligopoly vs Quasi-Monopoly. Pricing power: Strong vs Moderate.
  • Moat breadth: Hermes International Societe en commandite par actions has 5 moat types across 2 domains; West Pharmaceutical Services, Inc. has 5 across 3.

Primary market context

Hermes International Societe en commandite par actions

Leather Goods and Saddlery

Market

Ultra-premium leather goods and luxury handbags

Geography

Global

Customer

Affluent consumers

Role

Brand owner, artisan manufacturer, direct retailer

Revenue share

42.6%

West Pharmaceutical Services, Inc.

Proprietary Products

Market

Injectable primary packaging components and containment/delivery systems (elastomeric stoppers, seals, plungers, syringe/cartridge components; related services)

Geography

Global

Customer

Biologic, generic, and pharmaceutical drug manufacturers

Role

Primary packaging and delivery component supplier

Revenue share

80.7%

Side-by-side metrics

Hermes International Societe en commandite par actions
West Pharmaceutical Services, Inc.
Ticker / Exchange
RMS - Euronext Paris
WST - New York Stock Exchange
Market cap (USD)
$261.7B
n/a
Sector
Consumer
Healthcare
HQ country
FR
US
Primary segment
Leather Goods and Saddlery
Proprietary Products
Market structure
Oligopoly
Quasi-Monopoly
Market share
n/a
70%-75% (reported)
HHI estimate
n/a
n/a
Pricing power
Strong
Moderate
Moat score
79 / 100
85 / 100
Moat domains
Demand, Supply
Demand, Legal, Supply
Last update
2025-12-30
2025-12-22

Moat coverage

Shared moat types

Brand TrustOperational Excellence

Hermes International Societe en commandite par actions strengths

Capacity MoatSupply Chain ControlDistribution Control

West Pharmaceutical Services, Inc. strengths

Design In QualificationCompliance AdvantageCapex Knowhow Scale

Segment mix

Hermes International Societe en commandite par actions segments

Full profile >

Leather Goods and Saddlery

Oligopoly

42.6%

Ready-to-wear and Accessories

Competitive

29%

Silk and Textiles

Competitive

6.3%

Other Hermes sectors (Jewelry, Home, etc.)

Competitive

12.6%

Perfume and Beauty

Competitive

3.5%

Watches

Competitive

3.8%

Other products (Third-party production)

Competitive

2.2%

West Pharmaceutical Services, Inc. segments

Full profile >

Proprietary Products

Quasi-Monopoly

80.7%

Contract-Manufactured Products

Competitive

19.3%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.